This seems to be in contrast with previous literature that suggested that APRIL and BAFF are potential markers of myeloma disease activity;19 however, given that these proteins are involved in normal B-cell functioning, this may suggest their complex role in the immune dysregulation that precedes the clonal proliferation of malignant plasma cells. Here, TNFSF13 is linked to plasma cell myeloma.